Clinical Trial Update: Effects of Evolocumab on Platelet Reactivity in Patients With Diabetes Mellitus [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effects of evolocumab on platelet reactivity in patients with type 2 diabetes and dyslipidemia; study terminated with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia Associated with Type Ii Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Inova Health Care Services | Conditions: Diabetes Mellitus, Type 2, Dyslipidemia Associated With Type II Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2023-01-19